IDEAYA Biosciences (IDYA) Financial Statements
Price: $16.35
Market Cap: $1.43B
Avg Volume: 943.04K
Market Cap: $1.43B
Avg Volume: 943.04K
Country: US
Industry: Biotechnology
Sector: Healthcare
Industry: Biotechnology
Sector: Healthcare
Overview of Financial Statements
Financial statements are records that provide an overview of a company's financial performance and position. There are three main types of financial statements:
- Income Statement: Shows the company's revenue, expenses, and profit over a specific period.
- Balance Sheet: Provides a snapshot of the company's assets, liabilities, and equity at a specific point in time.
- Cash Flow Statement: Details the cash inflows and outflows from operating, investing, and financing activities over a period.
This page presents both annual and quarterly data for these financial statements. The charts below provide a visual representation of the key metrics from each statement, helping you to quickly understand the financial health of IDEAYA Biosciences.
Income Statement
| Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 | December 31, 2019 | December 31, 2018 | December 31, 2017 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $7.00M | $23.39M | $50.93M | $27.94M | $19.54M | $- | $- | $- |
| Cost of Revenue | $- | $4.01M | $2.10M | $1.73M | $39.70M | $1.25M | $886.00K | $391.00K |
| Gross Profit | $7.00M | $19.38M | $48.83M | $26.22M | $-20.16M | $-1.25M | $-886.00K | $-391.00K |
| Gross Profit Ratio | 100.00% | 82.90% | 95.87% | 93.80% | -103.18% | 0.00% | 0.00% | 0.00% |
| Research and Development Expenses | $294.67M | $129.51M | $89.54M | $58.16M | $39.70M | $34.32M | $31.75M | $12.38M |
| General and Administrative Expenses | $39.30M | $28.31M | $23.90M | $20.05M | $15.18M | $9.95M | $4.67M | $2.05M |
| Selling and Marketing Expenses | $- | $- | $- | $- | $- | $- | $- | $- |
| Selling General and Administrative Expenses | $39.30M | $28.31M | $23.90M | $20.05M | $15.18M | $9.95M | $4.67M | $2.05M |
| Other Expenses | $- | $- | $- | $- | $- | $8.00K | $77.00K | $2.43M |
| Operating Expenses | $333.98M | $157.81M | $113.43M | $78.21M | $54.88M | $44.27M | $36.42M | $14.44M |
| Cost and Expenses | $333.98M | $157.81M | $113.43M | $78.21M | $54.88M | $44.27M | $36.42M | $14.44M |
| Interest Income | $52.50M | $21.47M | $3.85M | $506.00K | $849.00K | $2.29M | $1.99M | $150.00K |
| Interest Expense | $- | $- | $3.85M | $- | $849.00K | $- | $- | $- |
| Depreciation and Amortization | $- | $4.01M | $2.10M | $1.73M | $1.38M | $1.25M | $886.00K | $391.00K |
| EBITDA | $-326.98M | $-130.42M | $-60.40M | $-48.54M | $-33.96M | $-43.03M | $-35.53M | $-14.05M |
| EBITDA Ratio | -4671.07% | -557.71% | -122.72% | -179.91% | -180.90% | 0.00% | 0.00% | 0.00% |
| Operating Income | $-326.98M | $-134.43M | $-62.50M | $-50.27M | $-35.34M | $-44.27M | $-36.42M | $-14.44M |
| Operating Income Ratio | -4671.07% | -574.85% | -122.72% | -179.91% | -180.90% | 0.00% | 0.00% | 0.00% |
| Total Other Income Expenses Net | $52.50M | $21.47M | $3.85M | $506.00K | $849.00K | $2.30M | $2.07M | $2.58M |
| Income Before Tax | $-274.48M | $-112.96M | $-58.66M | $-49.76M | $-34.49M | $-41.98M | $-34.35M | $-11.86M |
| Income Before Tax Ratio | -3921.10% | -483.05% | -115.17% | -178.10% | -176.55% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | $- | $- | $-3.85M | $-2.23M | $-2.23M | $-3.53M | $2.07M | $-150.00K |
| Net Income | $-274.48M | $-112.96M | $-54.81M | $-47.53M | $-32.27M | $-38.44M | $-34.35M | $-11.86M |
| Net Income Ratio | -3921.10% | -483.05% | -107.61% | -170.11% | -165.14% | 0.00% | 0.00% | 0.00% |
| EPS | $-3.36 | $-1.96 | $-1.32 | $-1.35 | $-1.31 | $-1.90 | $-2.41 | $-0.83 |
| EPS Diluted | $-3.36 | $-1.96 | $-1.32 | $-1.35 | $-1.31 | $-1.90 | $-2.41 | $-0.83 |
| Weighted Average Shares Outstanding | 81.68M | 57.52M | 41.44M | 35.25M | 24.72M | 20.23M | 14.24M | 14.24M |
| Weighted Average Shares Outstanding Diluted | 81.68M | 57.52M | 41.44M | 35.25M | 24.72M | 20.23M | 14.24M | 14.24M |
| SEC Filing | Source | Source | Source | Source | Source | Source | Source | Source |
Balance Sheet
| Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 | December 31, 2019 | December 31, 2018 | December 31, 2017 |
|---|---|---|---|---|---|---|---|---|
| Cash and Cash Equivalents | $84.38M | $157.02M | $68.63M | $92.05M | $72.04M | $34.07M | $20.50M | $5.96M |
| Short Term Investments | $591.94M | $368.10M | $296.20M | $154.72M | $211.55M | $64.89M | $69.46M | $7.20M |
| Cash and Short Term Investments | $676.32M | $525.11M | $373.15M | $368.06M | $283.58M | $100.48M | $89.96M | $13.16M |
| Net Receivables | $3.00K | $18.00K | $211.00K | $1.10M | $1.88M | $- | $- | $- |
| Inventory | $- | $- | $-8.32M | $-121.29M | $- | $- | $- | $- |
| Other Current Assets | $13.39M | $7.50M | $5.41M | $6.25M | $6.29M | $5.40M | $706.00K | $419.00K |
| Total Current Assets | $689.71M | $532.63M | $370.45M | $251.00M | $288.61M | $100.48M | $90.67M | $13.58M |
| Property Plant Equipment Net | $27.74M | $8.41M | $8.99M | $8.66M | $9.48M | $9.70M | $5.15M | $3.74M |
| Goodwill | $- | $- | $- | $- | $- | $- | $- | $- |
| Intangible Assets | $- | $- | $- | $- | $- | $- | $- | $- |
| Goodwill and Intangible Assets | $- | $- | $- | $- | $- | $- | $- | $- |
| Long Term Investments | $- | $107.49M | $8.32M | $121.29M | $106.00K | $1.53M | $106.00K | $71.00K |
| Tax Assets | $- | $- | $- | $- | $- | $- | $- | $- |
| Other Non-Current Assets | $406.64M | $782.00K | $205.00K | $397.00K | $82.00K | $1.29M | $616.00K | $89.00K |
| Total Non-Current Assets | $434.38M | $116.68M | $17.52M | $130.35M | $9.66M | $12.52M | $5.87M | $3.90M |
| Other Assets | $- | $- | $- | $- | $- | $- | $- | $- |
| Total Assets | $1.12B | $649.32M | $387.97M | $381.35M | $298.27M | $113.00M | $96.54M | $17.48M |
| Account Payables | $15.42M | $6.60M | $4.28M | $2.10M | $953.00K | $709.00K | $1.42M | $662.00K |
| Short Term Debt | $596.00K | $1.75M | $3.74M | $3.40M | $3.08M | $1.15M | $- | $- |
| Tax Payables | $- | $- | $- | $- | $- | $- | $- | $- |
| Deferred Revenue | $- | $- | $8.57M | $29.04M | $27.61M | $5.02M | $299.00K | $297.00K |
| Other Current Liabilities | $30.05M | $18.76M | $25.01M | $17.27M | $6.99M | $5.09M | $3.70M | $1.48M |
| Total Current Liabilities | $46.07M | $27.10M | $31.72M | $45.16M | $38.64M | $6.94M | $5.41M | $2.43M |
| Long Term Debt | $18.87M | $1.12M | $1.61M | $3.48M | $5.18M | $- | $- | $3.21M |
| Deferred Revenue Non-Current | $- | $- | $5.18M | $31.19M | $56.16M | $- | $- | $- |
| Deferred Tax Liabilities Non-Current | $- | $- | $-5.18M | $-31.19M | $- | $- | $- | $- |
| Other Non-Current Liabilities | $- | $- | $- | $- | $12.00K | $5.66M | $140.08M | $27.58M |
| Total Non-Current Liabilities | $18.87M | $1.12M | $6.80M | $34.67M | $61.35M | $5.66M | $140.08M | $30.78M |
| Other Liabilities | $- | $- | $349.45M | $301.51M | $198.27M | $100.40M | $- | $- |
| Total Liabilities | $64.94M | $28.23M | $387.97M | $381.35M | $298.27M | $113.00M | $145.49M | $33.22M |
| Preferred Stock | $- | $- | $- | $- | $- | $113.00M | $138.39M | $26.08M |
| Common Stock | $9.00K | $7.00K | $5.00K | $4.00K | $3.00K | $2.00K | $1.00K | $1.00K |
| Retained Earnings | $-622.84M | $-348.36M | $-235.40M | $-176.75M | $-126.99M | $-92.49M | $-50.52M | $-16.17M |
| Accumulated Other Comprehensive Income Loss | $812.00K | $562.00K | $-2.87M | $-712.00K | $7.00K | $65.00K | $-31.00K | $-1.00K |
| Other Total Stockholders Equity | $1.68B | $968.88M | $587.72M | $478.97M | $325.25M | $192.82M | $-136.79M | $-26.08M |
| Total Stockholders Equity | $1.06B | $621.09M | $349.45M | $301.51M | $198.27M | $100.40M | $-48.95M | $-15.74M |
| Total Equity | $1.06B | $621.09M | $349.45M | $301.51M | $198.27M | $100.40M | $-48.95M | $-15.74M |
| Total Liabilities and Stockholders Equity | $1.12B | $649.32M | $387.97M | $381.35M | $298.27M | $113.00M | $96.54M | $17.48M |
| Minority Interest | $- | $- | $- | $- | $- | $- | $- | $- |
| Total Liabilities and Total Equity | $1.12B | $649.32M | $387.97M | $381.35M | $298.27M | $113.00M | $96.54M | $17.48M |
| Total Investments | $591.94M | $475.59M | $304.51M | $276.02M | $211.55M | $66.42M | $69.46M | $7.20M |
| Total Debt | $19.17M | $2.87M | $3.48M | $5.18M | $6.72M | $6.77M | $- | $3.21M |
| Net Debt | $-65.21M | $-154.15M | $-65.15M | $-86.86M | $-65.31M | $-27.30M | $-20.50M | $-2.75M |
Cash Flow Statement
| Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 | December 31, 2019 | December 31, 2018 | December 31, 2017 |
|---|---|---|---|---|---|---|---|---|
| Net Income | $-274.48M | $-112.96M | $-58.66M | $-49.76M | $-34.49M | $-41.98M | $-34.35M | $-11.86M |
| Depreciation and Amortization | $3.83M | $4.01M | $2.10M | $1.73M | $1.38M | $1.25M | $886.00K | $391.00K |
| Deferred Income Tax | $- | $- | $- | $- | $- | $- | $-873.00K | $-27.00K |
| Stock Based Compensation | $34.75M | $18.49M | $11.63M | $8.24M | $3.61M | $2.17M | $950.00K | $136.00K |
| Change in Working Capital | $11.55M | $-13.21M | $-41.55M | $-17.81M | $84.41M | $-284.00K | $1.65M | $1.56M |
| Accounts Receivables | $15.00K | $193.00K | $892.00K | $774.00K | $-1.88M | $- | $- | $- |
| Inventory | $- | $- | $- | $3.79M | $2.29M | $- | $- | $- |
| Accounts Payables | $8.28M | $2.63M | $1.86M | $1.17M | $225.00K | $-195.00K | $322.00K | $254.00K |
| Other Working Capital | $3.25M | $-16.04M | $-44.31M | $-23.54M | $83.77M | $-89.00K | $1.33M | $1.31M |
| Other Non Cash Items | $-23.23M | $-11.55M | $-695.00K | $1.83M | $562.00K | $-467.00K | $4.11M | $-2.43M |
| Net Cash Provided by Operating Activities | $-247.58M | $-115.22M | $-87.17M | $-55.78M | $55.46M | $-39.31M | $-27.62M | $-12.22M |
| Investments in Property Plant and Equipment | $-3.86M | $-2.37M | $-3.44M | $-2.64M | $-493.00K | $-1.35M | $-1.71M | $-1.76M |
| Acquisitions Net | $- | $- | $33.40M | $67.02M | $-18.00K | $-8.00K | $- | $- |
| Purchases of Investments | $-1.19B | $-595.98M | $-255.81M | $-315.00M | $-242.31M | $-88.00M | $-133.30M | $-13.47M |
| Sales Maturities of Investments | $692.61M | $439.89M | $225.85M | $247.97M | $96.56M | $91.62M | $71.83M | $6.30M |
| Other Investing Activities | $- | $- | $-33.40M | $-67.02M | $18.00K | $8.00K | $-61.47M | $-7.17M |
| Net Cash Used for Investing Activities | $-502.56M | $-158.46M | $-33.40M | $-69.67M | $-146.24M | $2.27M | $-63.18M | $-8.93M |
| Debt Repayment | $- | $- | $- | $- | $- | $- | $- | $- |
| Common Stock Issued | $654.23M | $309.76M | $94.96M | $143.25M | $127.23M | $50.32M | $105.38M | $17.49M |
| Common Stock Repurchased | $- | $- | $- | $- | $- | $- | $- | $- |
| Dividends Paid | $- | $- | $- | $- | $- | $- | $- | $- |
| Other Financing Activities | $23.32M | $52.95M | $2.20M | $2.20M | $1.52M | $289.00K | $105.38M | $17.49M |
| Net Cash Used Provided by Financing Activities | $677.55M | $362.72M | $97.17M | $145.45M | $128.75M | $50.61M | $105.38M | $17.49M |
| Effect of Forex Changes on Cash | $- | $- | $- | $- | $- | $- | $- | $- |
| Net Change in Cash | $-72.59M | $89.04M | $-23.41M | $20.01M | $37.97M | $13.56M | $14.58M | $-3.66M |
| Cash at End of Period | $85.18M | $157.78M | $68.74M | $92.15M | $72.14M | $34.17M | $20.61M | $6.03M |
| Cash at Beginning of Period | $157.78M | $68.74M | $92.15M | $72.14M | $34.17M | $20.61M | $6.03M | $9.69M |
| Operating Cash Flow | $-247.58M | $-115.22M | $-87.17M | $-55.78M | $55.46M | $-39.31M | $-27.62M | $-12.22M |
| Capital Expenditure | $-3.86M | $-2.37M | $-3.44M | $-2.64M | $-493.00K | $-1.35M | $-1.71M | $-1.76M |
| Free Cash Flow | $-251.44M | $-117.59M | $-90.62M | $-58.42M | $54.97M | $-40.67M | $-29.33M | $-13.98M |